12 Undervalued Financial Stocks to Buy Now

8. Marsh & McLennan Companies, Inc. (NYSE:MRSH)

On May 26, 2026, Piper Sandler analyst Paul Newsome lowered the firm’s price target on Marsh & McLennan Companies, Inc. (NYSE:MRSH) to $182 from $190 and maintained a Neutral rating on the shares. Newsome cited recent stock performance and the roll-forward of estimates.

On May 21, 2026, Morgan Stanley lowered the firm’s price target on Marsh & McLennan Companies, Inc. (NYSE:MRSH) to $180 from $190 and maintained an Equal Weight rating on the shares. Morgan Stanley noted that most property and casualty insurance companies saw slower premium growth but substantial underwriting profit in Q1, while expecting pricing and premiums to deteriorate further. Earlier in May, Citi analyst Matthew Heimermann upgraded Marsh McLennan to Buy from Neutral with an unchanged $200 price target, citing valuation and saying cyclical growth pressures should ease over the next few quarters.

Last month, Marsh & McLennan Companies, Inc. (NYSE:MRSH) reported Q1 adjusted EPS of $3.29, ahead of the consensus estimate of $3.22. Revenue totaled $7.6B, above the consensus estimate of $7.4B. President and CEO John Doyle said the company had a “solid start” to the year, citing 8% overall revenue growth, 4% underlying revenue growth, 8% adjusted operating income growth, and 8% adjusted EPS growth.

Marsh & McLennan Companies, Inc. (NYSE:MRSH) provides advisory services and insurance solutions in the areas of risk, strategy, and people worldwide.